A malaria vaccine created by Oxford researchers “is really exciting” and could contribute towards drastically reducing the number of children who die from the infection, experts suggest.
A new study reports on the effectiveness of a malaria booster vaccine which shows long-lasting high efficacy in African children, meeting the World Health Organisation (WHO) specified 75% efficacy goal.
The research found that a vaccine booster dose one year after children received three doses as their primary vaccination regime maintained high efficacy against malaria.
Adrian Hill, director of the Jenner Institute and Lakshmi Mittal and Family Professor of Vaccinology, University of Oxford, said: “We think these data are the best data yet.
“And very importantly, this is a vaccine that we think can be manufactured and deployed, very widely.”
He added that the vaccine could be produced for a few dollars a dose, and together with existing measures, like mosquito nets and sprays, could help save children’s lives.
Read full story
Source: The Independent, 8 September 2022